Your browser doesn't support javascript.
loading
Circulating Metabolites Associated with Alcohol Intake in the European Prospective Investigation into Cancer and Nutrition Cohort.
van Roekel, Eline H; Trijsburg, Laura; Assi, Nada; Carayol, Marion; Achaintre, David; Murphy, Neil; Rinaldi, Sabina; Schmidt, Julie A; Stepien, Magdalena; Kaaks, Rudolf; Kühn, Tilman; Boeing, Heiner; Iqbal, Khalid; Palli, Domenico; Krogh, Vittorio; Tumino, Rosario; Ricceri, Fulvio; Panico, Salvatore; Peeters, Petra H; Bueno-de-Mesquita, Bas; Ardanaz, Eva; Lujan-Barroso, Leila; Quirós, J Ramón; Huerta, José M; Molina-Portillo, Elena; Dorronsoro, Miren; Tsilidis, Konstantinos K; Riboli, Elio; Rostgaard-Hansen, Agnetha Linn; Tjønneland, Anne; Overvad, Kim; Weiderpass, Elisabete; Boutron-Ruault, Marie-Christine; Severi, Gianluca; Trichopoulou, Antonia; Karakatsani, Anna; Kotanidou, Anastasia; Håkansson, Anders; Malm, Johan; Weijenberg, Matty P; Gunter, Marc J; Jenab, Mazda; Johansson, Mattias; Travis, Ruth C; Scalbert, Augustin; Ferrari, Pietro.
Afiliação
  • van Roekel EH; Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, 6229 HA Maastricht, The Netherlands. eline.vanroekel@maastrichtuniversity.nl.
  • Trijsburg L; Nutritional Methodology and Biostatistics Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France. laura.trijsburg@wur.nl.
  • Assi N; Nutritional Methodology and Biostatistics Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France. assin@students.iarc.fr.
  • Carayol M; Epidaure, Prevention Department of the Institut régional du Cancer de Montpellier (ICM), 34298 Montpellier, France. Marion.Carayol@icm.unicancer.fr.
  • Achaintre D; Laboratoire Epsylon, Paul Valery University of Montpellier, 34090 Montpellier, France. Marion.Carayol@icm.unicancer.fr.
  • Murphy N; Biomarkers Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France. achaintred@iarc.fr.
  • Rinaldi S; Nutritional Epidemiology Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France. MurphyN@iarc.fr.
  • Schmidt JA; Biomarkers Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France. rinaldis@iarc.fr.
  • Stepien M; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK. julie.schmidt@ndph.ox.ac.uk.
  • Kaaks R; Nutritional Epidemiology Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France. StepienM@iarc.fr.
  • Kühn T; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. r.kaaks@dkfz-heidelberg.de.
  • Boeing H; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. t.kuehn@Dkfz-Heidelberg.de.
  • Iqbal K; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany. boeing@dife.de.
  • Palli D; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany. khalid.iqbal@dife.de.
  • Krogh V; Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, 50141 Florence, Italy. d.palli@ispo.toscana.it.
  • Tumino R; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. Vittorio.Krogh@istitutotumori.mi.it.
  • Ricceri F; Cancer Registry and Histopathology Department, Civic-M.P.Arezzo Hospital, ASP, 97100 Ragusa, Italy. rtumino@tin.it.
  • Panico S; Department of Clinical and Biological Sciences, University of Turin, 10124 Turin, Italy. fulvio.ricceri@unito.it.
  • Peeters PH; Unit of Epidemiology, Regional Health Service ASL TO3, 10095 Turin, Italy. fulvio.ricceri@unito.it.
  • Bueno-de-Mesquita B; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, 80138 Naples, Italy. spanico@unina.it.
  • Ardanaz E; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands. P.H.M.Peeters@umcutrecht.nl.
  • Lujan-Barroso L; Former Senior Scientist, Dept. for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands. basbuenodemesquita@gmail.com.
  • Quirós JR; Former Associate Professor, Department of Gastroenterology and Hepatology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands. basbuenodemesquita@gmail.com.
  • Huerta JM; Visiting Professor, Dept. of Epidemiology and Biostatistics, The School of Public Health, Imperial College, London SW7 2AZ, UK. basbuenodemesquita@gmail.com.
  • Molina-Portillo E; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia. basbuenodemesquita@gmail.com.
  • Dorronsoro M; Navarra Public Health Institute, 31003 Pamplona, Spain. me.ardanaz.aicua@cfnavarra.es.
  • Tsilidis KK; IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain. me.ardanaz.aicua@cfnavarra.es.
  • Riboli E; CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain. me.ardanaz.aicua@cfnavarra.es.
  • Rostgaard-Hansen AL; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain. llujan@iconcologia.net.
  • Tjønneland A; Public Health Directorate, 33005 Oviedo, Spain. epic_asturias@asturias.org.
  • Overvad K; CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain. jmhuerta.carm@gmail.com.
  • Weiderpass E; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, 30008 Murcia, Spain. jmhuerta.carm@gmail.com.
  • Boutron-Ruault MC; CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain. elena.molina.easp@juntadeandalucia.es.
  • Severi G; Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs, GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, 18010 Granada, Spain. elena.molina.easp@juntadeandalucia.es.
  • Trichopoulou A; Basque Regional Health Department, Public Health Direction and Biodonostia Research Institute CIBERESP, 20014 Donostia, Spain. m-dorronsoro@euskadi.eus.
  • Karakatsani A; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London SW7 2AZ, UK. ktsilidis@gmail.com.
  • Kotanidou A; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, 45110 Ioannina, Greece. ktsilidis@gmail.com.
  • Håkansson A; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London SW7 2AZ, UK. e.riboli@imperial.ac.uk.
  • Malm J; Danish Cancer Society Research Center, 2100 Copenhagen, Denmark. agnrha@cancer.dk.
  • Weijenberg MP; Danish Cancer Society Research Center, 2100 Copenhagen, Denmark. annet@CANCER.DK.
  • Gunter MJ; Department of Public Health, Section for Epidemiology, Aarhus University, 8000 Aarhus, Denmark. ko@ph.au.dk.
  • Jenab M; Department of Cardiology, Aalborg University Hospital, 9100 Aalborg, Denmark. ko@ph.au.dk.
  • Johansson M; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, 9019 Tromsø, Norway. Elisabete.Weiderpass.Vainio@ki.se.
  • Travis RC; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, NO-0304 Oslo, Norway. Elisabete.Weiderpass.Vainio@ki.se.
  • Scalbert A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden. Elisabete.Weiderpass.Vainio@ki.se.
  • Ferrari P; Genetic Epidemiology Group, Folkhälsan Research Center, 00290 Helsinki, Finland. Elisabete.Weiderpass.Vainio@ki.se.
Nutrients ; 10(5)2018 May 22.
Article em En | MEDLINE | ID: mdl-29789452
ABSTRACT
Identifying the metabolites associated with alcohol consumption may provide insights into the metabolic pathways through which alcohol may affect human health. We studied associations of alcohol consumption with circulating concentrations of 123 metabolites among 2974 healthy participants from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Alcohol consumption at recruitment was self-reported through dietary questionnaires. Metabolite concentrations were measured by tandem mass spectrometry (BIOCRATES AbsoluteIDQTM p180 kit). Data were randomly divided into discovery (2/3) and replication (1/3) sets. Multivariable linear regression models were used to evaluate confounder-adjusted associations of alcohol consumption with metabolite concentrations. Metabolites significantly related to alcohol intake in the discovery set (FDR q-value < 0.05) were further tested in the replication set (Bonferroni-corrected p-value < 0.05). Of the 72 metabolites significantly related to alcohol intake in the discovery set, 34 were also significant in the replication analysis, including three acylcarnitines, the amino acid citrulline, four lysophosphatidylcholines, 13 diacylphosphatidylcholines, seven acyl-alkylphosphatidylcholines, and six sphingomyelins. Our results confirmed earlier findings that alcohol consumption was associated with several lipid metabolites, and possibly also with specific acylcarnitines and amino acids. This provides further leads for future research studies aiming at elucidating the mechanisms underlying the effects of alcohol in relation to morbid conditions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Consumo de Bebidas Alcoólicas / Estado Nutricional / Estilo de Vida / Lipídeos / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Consumo de Bebidas Alcoólicas / Estado Nutricional / Estilo de Vida / Lipídeos / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article